Calidi Biotherapeutics, Inc. (CLDI)
NYSEAMERICAN: CLDI · Real-Time Price · USD
1.080
-0.100 (-8.47%)
At close: Oct 29, 2024, 4:00 PM
1.090
+0.010 (0.93%)
After-hours: Oct 29, 2024, 7:55 PM EDT

Calidi Biotherapeutics Statistics

Total Valuation

CLDI has a market cap or net worth of $12.00 million. The enterprise value is $19.90 million.

Market Cap 12.00M
Enterprise Value 19.90M

Important Dates

The next estimated earnings date is Tuesday, November 12, 2024, after market close.

Earnings Date Nov 12, 2024
Ex-Dividend Date n/a

Share Statistics

CLDI has 11.11 million shares outstanding. The number of shares has increased by 1,173.82% in one year.

Shares Outstanding 11.11M
Shares Change (YoY) +1,173.82%
Shares Change (QoQ) +49.86%
Owned by Insiders (%) 9.48%
Owned by Institutions (%) 2.94%
Float 9.16M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio n/a
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.12

Current Ratio 0.12
Quick Ratio 0.08
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -27.58

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -222.49%
Return on Capital (ROIC) n/a
Revenue Per Employee n/a
Profits Per Employee -$607,707
Employee Count 41
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, CLDI has paid $20,000 in taxes.

Income Tax 20,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -95.40% in the last 52 weeks. The beta is 0.60, so CLDI's price volatility has been lower than the market average.

Beta (5Y) 0.60
52-Week Price Change -95.40%
50-Day Moving Average 1.14
200-Day Moving Average 3.38
Relative Strength Index (RSI) 48.79
Average Volume (20 Days) 691,883

Short Selling Information

The latest short interest is 110,832, so 1.00% of the outstanding shares have been sold short.

Short Interest 110,832
Short Previous Month 282,137
Short % of Shares Out 1.00%
Short % of Float 1.21%
Short Ratio (days to cover) 1.88

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -29.57M
Pretax Income -29.96M
Net Income -24.92M
EBITDA -29.18M
EBIT -29.57M
Earnings Per Share (EPS) -$7.17
Full Income Statement

Balance Sheet

The company has $836,000 in cash and $8.73 million in debt, giving a net cash position of -$7.90 million or -$0.71 per share.

Cash & Cash Equivalents 836,000
Total Debt 8.73M
Net Cash -7.90M
Net Cash Per Share -$0.71
Equity (Book Value) -11.75M
Book Value Per Share -1.82
Working Capital -11.43M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$28.03 million and capital expenditures -$147,000, giving a free cash flow of -$28.18 million.

Operating Cash Flow -28.03M
Capital Expenditures -147,000
Free Cash Flow -28.18M
FCF Per Share -$2.54
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

CLDI does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -1,173.82%
Shareholder Yield -1,173.82%
Earnings Yield -207.64%
FCF Yield -234.80%

Analyst Forecast

The average price target for CLDI is $16.67, which is 1,443.52% higher than the current price. The consensus rating is "Strong Buy".

Price Target $16.67
Price Target Difference 1,443.52%
Analyst Consensus Strong Buy
Analyst Count 3
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on July 15, 2024. It was a reverse split with a ratio of 0.1:1.

Last Split Date Jul 15, 2024
Split Type Reverse
Split Ratio 0.1:1

Scores

Altman Z-Score n/a
Piotroski F-Score 1